Procleix Ultrio transcription-mediated amplification vs. serological blood screening in south-western Greece

Transfusion Medicine

Volumn 18, Issue 2, 2008, Pages 104-111

  Sgourou, A ^a   Karakantza, M ^a   Theodori, E ^a   Papadimitriou, C ^a   Theodorou, G L ^a   Davanos, N ^a   Thymianou, S ^a   Zoumbos, N C ^a   Mouzaki, A ^a,b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Blood donation; HBV; HCV; HIV; NAT; TMA

Indexed keywords

NUCLEIC ACID;

ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; GREECE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INCIDENCE; MASS SCREENING; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SEROLOGY; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; GENE AMPLIFICATION; HEPACIVIRUS; HEPATITIS B VIRUS; HIV-1; HUMANS; PATIENT SELECTION; SEROLOGIC TESTS; TRANSCRIPTION, GENETIC;

EID: 42049100587     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2008.00847.x     Document Type: Article

References (28)

1. Allain, J.-P 2000) Genomic screening for blood-borne viruses in transfusion settings. Clinical and Laboratory Haematology, 22, 1 10.
2. Allain, J.-P 2004) Occult hepatitis B virus infection: implications in transfusion. Vox Sanguinis, 86, 83 91.
3. Biswas, R., Tabor, E., Hsia, C.C. et al 2003) Comparative sensitivity of HBV NATs and HBs Ag assays for detection of acute HBV infection. Transfusion, 43, 788 798.
4. Brojer, E., Grabarczyk, P., Liszewski, G., Mikulska, M., Allain, J.-P. Letowska, M 2006) Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology, 44, 1666 1674.
5. Busch, M.P., Glynn, S.A., Wright, D.J. et al 2005) Relative sensitivities of licensed nuclei acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion, 45, 1853 1863.
6. TM ASSAY PERFORMANCE TRIAL. Testing Laboratory for IVD, Paul-Ehrich-Institute, Langen, Germany.
7. Delwart, E.L., Kalmin, N.D., Jones, T.S. et al 2004) First report of human immunodeficiency virus transmission via an RNA-screened blood donation. Vox Sanguinis, 86, 171 177.
8. Giachetti, C., Linnen, J.M., Kolk, D.P. et al 2002) Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA. Journal of Clinical Microbiology, 40, 2408 2419.
9. Gogos, C.A., Fouka, K.P., Nikiforidis, G. et al 2003) Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. European Journal of Epidemiology, 18, 551 557.
10. Guidelines for the Blood Transfusion Services in the UK (2005) [WWW document]. URL http://www.official-documents.co.uk/document/other/011703371S/ 011703371S.asp
11. Hennig, H., Puchta, I., Luhm, J. et al 2002) Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood, 100, 2637 2641.
12. Katsoulidou, A., Moschidis, Z., Sypsa, V. et al 2007) Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with low viral load. Vox Sanguinis, 92, 8 14.
13. Kleinman, S.H. Busch, M.P 2001) HBV amplified and back in the blood safety spotlight. Transfusion, 41, 1081 1085.
14. Kleinman, S.H. Busch, M.P 2006) Assessing the impact of HBV NAT on window period reduction and residual risk. Journal of Clinical Virology, 36 (Suppl. 1 S23 S29.
15. Kleinman, S.H., Kuhns, M.C., Todd, D.S. et al 2003) Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion, 43, 696 704.
16. Kleinman, S.H., Strong, D.M., Tegtmeier, G.G.E. et al 2005) Hepatitis B (HBV) screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion, 45, 1247 1257.
17. Koppelman, M.H., Assal, A., Chudy, M. et al 2005) Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion, 45, 1258 1266.
18. Koulentaki, M., Spanoudakis, S., Kantidaki, E. et al 1999) Prevalence of hepatitis B and C markers in volunteer blood donors in Crete. A 5-year study. Journal of Viral Hepatology, 6, 243 248.
19. Kuhns, M.C., Kleinman, S.H., McNamara, A.L. et al 2004) Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion, 44, 1332 1339.
20. Kyriakis, K.P., Foudoulaki, L.E., Papoulia, E.I. Sofroniadou, K.E 2000) Seroprevalence of hepatitis B surface antigen (HBsAg) among first-time and sporadic blood donors in Greece. 1991-1996. Transfusion Medicine, 10, 175 180.
21. Laperche, S., Bouchardeau, F., Maniez, M. et al 2004) Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load. Vox Sanguinis, 86, 198.
22. Lucey, C 2006) Brief report on the United States Food and Drug Administration Blood products Advisory Committee recommendations for management of donors and units testing positive for hepatitis B virus DNA. Vox Sanguinis, 91, 331 335.
23. Pisani, G., Cristiano, K., Saldanha, J. et al 2004) External quality assessment for the detection of blood-borne viruses in plasma by nucleic acid amplification technology: the first human immunodeficiency virus and hepatitis virus studies (HIV EQA/1 and HBV EQA/1) and the fifth hepatitis C virus study (HCV EQA/5). Vox Sanguinis, 87, 91 95.
24. Reesink, H.W. Allain, J.-P. (2007) Management od donors and blood products reactive for hepatitis B virus DNA. Vox Sanguinis, 91, 281.
25. Stamer, S.L 2002) US NAT yield: Where are we after 2 years? Transfusion Medicine, 12, 243 253.
26. Tseliou, P., Spiliotakara, A., Dimitracopoulos, G.O. et al 2000) Detection of hepatitis B virus DNA in blood units with anti-HBc as the only positive serological marker. Haematologia (Budap), 30, 159 165.
27. Vargo, J., Smith, K., Knott, C. et al 2002) Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA. Transfusion, 42, 876 885.
28. Zervou, E.K., Dalekos, G.N., Boumba, D.S. et al 2001) Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion, 41, 652 658.